CDSCO supports foundations to direct clinical preliminaries in COVID-19 Patients Kumar Jeetendra | April 18, 2020 The Central Drugs Standard Control Organization (CDSCO) has given a green sign to intrigued foundations to direct the clinical preliminary with gaining strength plasma in COVID-19 patients, according to the convention created by Indian Council of Medical Research (ICMR). In a notification in regards to the clinical preliminary of healing plasma in COVID-19 patients, the …
Maglumi-800:Detect COVID-19 and test beyond Kumar Jeetendra | May 13, 2020 WHO declared COVID-19 as pandemic on March 12th, 2020. The contagion has taken the world by storm leading to high mortality. Given the infectiousness of the disease and the rate at which the infection is spreading, the medical facilities need to be geared up to support best medical outcome for disease. WHO has been recommending …
Baxter India gets CDSCO gesture for utilization of its Oxiris channel in COVID-19 treatment Kumar Jeetendra | July 7, 2020 Healthcare firm Baxter India on Tuesday said it has received consent from the Central Drugs Standard Control Organisation (CDSCO) for the usage of its Oxiris blood purification filter to the treatment of COVID-19 patients. The filter is meant to be utilised in the seriously ill COVID-19 patients needing blood purification where excess inflammatory mediators are …
ICMR gives positive nod for HiMedia-Syngene COVID-19 antibody test kit, ELISafe19™ Kumar Jeetendra | September 10, 2020 The Indian Bioscience leader, Himedia Laboratories, an expert in media developer, manufacturer and diagnostics, has manufactured an IgG based ELISA test kit, ELISafe19™ for COVID-19 in collaboration with Syngene International, an integrated research and development services company. The antibody test kit has a sensitivity of 100% and specificity of 99% and has now been approved by …
